{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:05:42Z","timestamp":1790193942571,"version":"4.1.0"},"reference-count":99,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007313","name":"University of Texas MD Anderson Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100023736","name":"Office of the Vice President for Research and Partnerships","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100023736","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003887","name":"International Myeloma Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003887","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.canlet.2026.218355","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T17:08:42Z","timestamp":1772125722000},"page":"218355","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Therapy-induced rapid drug resistance driven by genome chaos and polyploid giant cancer cells"],"prefix":"10.1016","volume":"645","author":[{"given":"Steven D.","family":"Horne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing Christine","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Batoul Y.","family":"Abdallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua B.","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry H.","family":"Heng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2026.218355_bib1","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1200\/JCO.2012.43.4233","article-title":"Maximum-tolerated dose, optimum biologic dose, or optimum clinical value: dosing determination of cancer therapies","volume":"30","author":"Marshall","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2026.218355_bib2","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1146\/annurev.med.53.082901.103929","article-title":"Mechanisms of cancer drug resistance","volume":"53","author":"Gottesman","year":"2002","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.canlet.2026.218355_bib3","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1158\/1055-9965.1375.13.8","article-title":"Cancer prevention strategies that address the evolutionary dynamics of neoplastic cells: stimulating benign cell boosters and selection for chemosensitivity","volume":"13","author":"Maley","year":"2004","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.canlet.2026.218355_bib4","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.1752-4571.2012.00254.x","article-title":"Drugs that target pathogen public goods are robust against evolved drug resistance","volume":"5","author":"Pepper","year":"2012","journal-title":"Evol. Appl."},{"key":"10.1016\/j.canlet.2026.218355_bib5","series-title":"Targeted Therapies: Mechanisms of Resistance","first-page":"127","article-title":"Somatic evolution of acquired drug resistance in cancer","author":"Pepper","year":"2011"},{"key":"10.1016\/j.canlet.2026.218355_bib6","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1158\/0008-5472.CAN-08-3658","article-title":"Adaptive therapy","volume":"69","author":"Gatenby","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218355_bib7","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/emmm.201101131","article-title":"Role of intratumoural heterogeneity in cancer drug resistance: molecular and clinical perspectives","volume":"4","author":"Saunders","year":"2012","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.canlet.2026.218355_bib8","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1002\/cncr.26021","article-title":"Formation of solid tumors by a single multinucleated cancer cell","volume":"117","author":"Weihua","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2026.218355_bib9","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/onc.2013.96","article-title":"Generation of cancer stem-like cells through the formation of polyploid giant cancer cells","volume":"33","author":"Zhang","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2026.218355_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241411534","article-title":"Intratumor heterogeneity and treatment resistance of solid tumors with a focus on polyploid\/senescent giant cancer cells (PGCCs)","volume":"24","author":"Mirzayans","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2026.218355_bib11","article-title":"Targeting polyploid giant cancer cells potentiates a therapeutic response and overcomes resistance to PARP inhibitors in ovarian cancer","volume":"9","author":"Zhang","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.canlet.2026.218355_bib12","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.3390\/cancers16173106","article-title":"Amitotic cell division, malignancy, and resistance to anticancer agents: a tribute to Drs. Walen and Rajaraman","volume":"16","author":"Mirzayans","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canlet.2026.218355_bib13","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41388-022-02588-0","article-title":"Spatiotemporal view of malignant histogenesis and macroevolution via formation of polyploid giant cancer cells","volume":"42","author":"Li","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2026.218355_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.1017588","article-title":"Polyploid giant cancer cells and cancer progression","volume":"10","author":"Zhou","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.canlet.2026.218355_bib15","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.semcancer.2019.09.005","article-title":"The \"life code\": a theory that unifies the human life cycle and the origin of human tumors","volume":"60","author":"Liu","year":"2020","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.canlet.2026.218355_bib16","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.semcancer.2020.11.003","article-title":"Genome chaos: creating new genomic information essential for cancer macroevolution","volume":"81","author":"Heng","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.canlet.2026.218355_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/oncsis.2016.75","article-title":"Linking genomic reorganization to tumor initiation via the giant cell cycle","volume":"5","author":"Niu","year":"2016","journal-title":"Oncogenesis"},{"key":"10.1016\/j.canlet.2026.218355_bib18","doi-asserted-by":"crossref","first-page":"528","DOI":"10.4161\/cc.27378","article-title":"Genome chaos: survival strategy during crisis","volume":"13","author":"Liu","year":"2014","journal-title":"Cell Cycle"},{"key":"10.1016\/j.canlet.2026.218355_bib19","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12935-016-0311-8","article-title":"Temozolomide promotes genomic and phenotypic changes in glioblastoma cells","volume":"16","author":"Stepanenko","year":"2016","journal-title":"Cancer Cell Int."},{"issue":"34","key":"10.1016\/j.canlet.2026.218355_bib20","doi-asserted-by":"crossref","first-page":"4887","DOI":"10.1038\/onc.2017.72","article-title":"Dedifferentiation into blastomere-like cancer stem cells via formation of polyploid giant cancer cells","volume":"36","author":"Niu","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2026.218355_bib21","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/jcp.20685","article-title":"Stochastic cancer progression driven by non-clonal chromosome aberrations","volume":"208","author":"Heng","year":"2006","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.canlet.2026.218355_bib22","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3389\/fgene.2014.00092","article-title":"Stress, genomic adaptation, and the evolutionary trade-off","volume":"5","author":"Horne","year":"2014","journal-title":"Front. Genet."},{"key":"10.1016\/j.canlet.2026.218355_bib23","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10555-013-9436-6","article-title":"Aneuploidy and chromosomal instability: a vicious cycle driving cellular evolution and cancer genome chaos","volume":"32","author":"Potapova","year":"2013","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.canlet.2026.218355_bib24","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1002\/ijc.28531","article-title":"Unstable genomes elevate transcriptome dynamics","volume":"134","author":"Stevens","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2026.218355_bib25","doi-asserted-by":"crossref","first-page":"366","DOI":"10.3390\/genes10050366","article-title":"Micronuclei and genome chaos: changing the system inheritance","volume":"10","author":"Ye","year":"2019","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.canlet.2026.218355_bib26","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.3389\/fgene.2019.01082","article-title":"What is karyotype coding and why is genomic topology important for cancer and evolution?","volume":"10","author":"Ye","year":"2019","journal-title":"Front. Genet."},{"key":"10.1016\/j.canlet.2026.218355_bib27","series-title":"Genome Chaos: Rethinking Genetics, Evolution and Molecular Medicine","first-page":"556","author":"Heng","year":"2019"},{"key":"10.1016\/j.canlet.2026.218355_bib28","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3390\/cancers10010004","article-title":"The role of chromosomal instability in cancer and therapeutic responses","volume":"10","author":"Vargas-Rond\u00f3n","year":"2018","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canlet.2026.218355_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.676344","article-title":"Therapy-induced genome chaos: a novel mechanism of rapid cancer drug resistance","volume":"9","author":"Ye","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.canlet.2026.218355_bib30","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/s43018-023-00711-y","article-title":"Aneuploidy and complex genomic rearrangements in cancer evolution","volume":"5","author":"Baker","year":"2024","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.canlet.2026.218355_bib31","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41571-024-00923-w","article-title":"Targeting chromosomal instability in patients with cancer","volume":"21","author":"Al-Rawi","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2026.218355_bib32","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.cell.2015.01.026","article-title":"Targeting the adaptability of heterogeneous aneuploids","volume":"160","author":"Chen","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218355_bib33","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/jcp.24233","article-title":"Why imatinib remains an exception of cancer research","volume":"228","author":"Horne","year":"2013","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.canlet.2026.218355_bib34","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1126\/science.1256007","article-title":"What are the chances?","volume":"345","author":"Limbrick-Oldfield","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.canlet.2026.218355_bib35","series-title":"Debating Cancer: the Paradox in Cancer Research","first-page":"464","author":"Heng","year":"2015"},{"key":"10.1016\/j.canlet.2026.218355_bib36","article-title":"Profiling the genomic landscape and evolutionary history of polyploid giant cancer cells in undifferentiated pleomorphic sarcomas","author":"Bowes","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218355_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.218137","article-title":"Dormant and activated polyploid giant cancer cells: from chemoradiotherapy resistance to cancer progression","volume":"636","author":"Liu","year":"2026","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218355_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217447","article-title":"Meeting report: 1st international conference on polyploid giant cancer cells-biology, clinical applications, and the birth of a new field in cancer research","volume":"612","author":"Wu","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218355_bib39","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/bies.200800182","article-title":"The genome-centric concept: resynthesis of evolutionary theory","volume":"31","author":"Heng","year":"2009","journal-title":"Bioessays"},{"issue":"17","key":"10.1016\/j.canlet.2026.218355_bib40","doi-asserted-by":"crossref","first-page":"9163","DOI":"10.3390\/ijms25179163","article-title":"The spiral model of evolution: stable life forms of organisms and unstable life forms of cancers","volume":"25","author":"Kasperski","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2026.218355_bib41","series-title":"Genome Chaos: Rethinking Genetics, Evolution and Molecular Medicine","author":"Heng","year":"2025"},{"issue":"3","key":"10.1016\/j.canlet.2026.218355_bib42","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/eva.12359","article-title":"Third International biannual evolution and cancer conference (Evolutionary Trade\u2010offs and Clinical Consequences) meeting report. San Francisco, CA, USA. 10\u201313 December 2015","volume":"9","author":"Roche","year":"2016","journal-title":"Evol. Appl."},{"key":"10.1016\/j.canlet.2026.218355_bib99","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1126\/science.273.5274.494","article-title":"Multicolor spectral karyotyping of human chromosomes","volume":"273","author":"Schr\u00f6ck","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.canlet.2026.218355_bib43","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.4161\/cc.26580","article-title":"Single cell heterogeneity: why unstable genomes are incompatible with average profiles","volume":"12","author":"Abdallah","year":"2013","journal-title":"Cell Cycle"},{"key":"10.1016\/j.canlet.2026.218355_bib44","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.cellbi.2005.10.008","article-title":"Segregation of genomes in polyploid tumour cells following mitotic catastrophe","volume":"29","author":"Erenpreisa","year":"2005","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.canlet.2026.218355_bib45","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1042\/CBI20090502","article-title":"Mitosis is not the only distributor of mutated cells: non-mitotic endopolyploid cells produce reproductive genome-reduced cells","volume":"34","author":"Walen","year":"2010","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.canlet.2026.218355_bib46","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.mrrev.2017.05.002","article-title":"Transient and stable vector transfection: pitfalls, off-target effects, artifacts","volume":"773","author":"Stepanenko","year":"2017","journal-title":"Mutat. Res."},{"key":"10.1016\/j.canlet.2026.218355_bib47","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1126\/science.1239947","article-title":"Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma","volume":"343","author":"Johnson","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.canlet.2026.218355_bib48","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nature14410","article-title":"Whole-genome characterization of chemoresistant ovarian cancer","volume":"521","author":"Patch","year":"2015","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.canlet.2026.218355_bib49","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/s41388-024-03212-z","article-title":"Polyploid cancer cells reveal signatures of chemotherapy resistance","volume":"44","author":"Schmidt","year":"2025","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.canlet.2026.218355_bib50","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1158\/1541-7786.MCR-24-0689","article-title":"Cells in the polyaneuploid cancer cell state are prometastatic","volume":"23","author":"Mallin","year":"2025","journal-title":"Mol. Cancer Res. : MCR"},{"key":"10.1016\/j.canlet.2026.218355_bib51","article-title":"Polyploid giant cancer cells and tumor budding: translation from basic research to clinical application","volume":"15","author":"Huang","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2026.218355_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.567116","article-title":"Polyploid giant cancer cells, a hallmark of oncoviruses and a new therapeutic challenge","volume":"10","author":"Herbein","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2026.218355_bib53","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/978-1-0716-3946-7_14","article-title":"Characterizing Chemotherapy\/radiotherapy-induced genome chaos in Hodgkin's Lymphoma patients using M-FISH","volume":"2825","author":"Ramos","year":"2024","journal-title":"Methods Mol. Biol."},{"issue":"21","key":"10.1016\/j.canlet.2026.218355_bib54","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1182\/blood.2024026919","article-title":"TCA cycle mode switch determines the fate of pirtobrutinib-tolerant persister cells in mantle cell lymphoma","volume":"146","author":"Wang","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2026.218355_bib55","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.semcancer.2021.06.007","article-title":"Giant cells: linking McClintock's heredity to early embryogenesis and tumor origin throughout millennia of evolution on Earth","volume":"81","author":"Liu","year":"2022","journal-title":"Semin. Cancer Biol."},{"issue":"3","key":"10.1016\/j.canlet.2026.218355_bib56","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000348682","article-title":"Karyotype heterogeneity and unclassified chromosomal abnormalities","volume":"139","author":"Heng","year":"2013","journal-title":"Cytogenet. Genome Res."},{"key":"10.1016\/j.canlet.2026.218355_bib57","first-page":"56","article-title":"Step-wise and punctuated genome evolution drive phenotype changes of tumor cells","volume":"771","author":"Stepanenko","year":"2015","journal-title":"Mutat. Res."},{"key":"10.1016\/j.canlet.2026.218355_bib58","doi-asserted-by":"crossref","first-page":"14793","DOI":"10.1073\/pnas.1618215113","article-title":"Chromosome instability drives phenotypic switching to metastasis","volume":"113","author":"Gao","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.canlet.2026.218355_bib59","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.2174\/1389450111007011304","article-title":"Genetic and epigenetic heterogeneity in cancer: the ultimate challenge for drug therapy","volume":"11","author":"Heng","year":"2010","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.canlet.2026.218355_bib60","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10555-013-9427-7","article-title":"Chromosomal instability (CIN): what it is and why it is crucial to cancer evolution","volume":"32","author":"Heng","year":"2013","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.canlet.2026.218355_bib61","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nature09807","article-title":"Tumour evolution inferred by single-cell sequencing","volume":"472","author":"Navin","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218355_bib62","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cell.2010.12.025","article-title":"Cancer genomes evolve by pulverizing single chromosomes","volume":"144","author":"Meyerson","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218355_bib63","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cell.2010.11.055","article-title":"Massive genomic rearrangement acquired in a single catastrophic event during cancer development","volume":"144","author":"Stephens","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218355_bib64","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1038\/nm.2988","article-title":"Chromoanagenesis and cancer: mechanisms and consequences of localized, complex chromosomal rearrangements","volume":"18","author":"Holland","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2026.218355_bib65","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.cell.2013.03.021","article-title":"Punctuated evolution of prostate cancer genomes","volume":"153","author":"Baca","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218355_bib66","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/nature13600","article-title":"Clonal evolution in breast cancer revealed by single nucleus genome sequencing","volume":"512","author":"Wang","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218355_bib67","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1038\/ng.3641","article-title":"Punctuated copy number evolution and clonal stasis in triple-negative breast cancer","volume":"48","author":"Gao","year":"2016","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2026.218355_bib68","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13039-016-0297-x","article-title":"Inherent variability of cancer-specific aneuploidy generates metastases","volume":"9","author":"Bloomfield","year":"2016","journal-title":"Mol. Cytogenet."},{"key":"10.1016\/j.canlet.2026.218355_bib69","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nature25432","article-title":"Chromosomal instability drives metastasis through a cytosolic DNA response","volume":"553","author":"Bakhoum","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218355_bib70","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/ng.3214","article-title":"A big bang model of human colorectal tumor growth","volume":"47","author":"Sottoriva","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2026.218355_bib71","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/s41588-019-0423-x","article-title":"Quantitative evidence for early metastatic seeding in colorectal cancer","volume":"51","author":"Hu","year":"2019","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2026.218355_bib72","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s10555-013-9435-7","article-title":"Genetic and non-genetic instability in tumor progression: link between the fitness landscape and the epigenetic landscape of cancer cells","volume":"32","author":"Huang","year":"2013","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.canlet.2026.218355_bib73","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1462496","article-title":"Genomic instability as a driver and suppressor of anti-tumor immunity","volume":"15","author":"Requesens","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2026.218355_bib74","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41422-023-00876-2","article-title":"Chromosomal instability drives immunosuppression and metastatic dissemination","volume":"34","author":"Vitale","year":"2024","journal-title":"Cell Res."},{"key":"10.1016\/j.canlet.2026.218355_bib75","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.895961","article-title":"Chromosome instability and aneuploidy as context-dependent activators or inhibitors of antitumor immunity","volume":"13","author":"Kuang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2026.218355_bib76","series-title":"Ovarian Cancer: the Recognition and Initial Management of Ovarian Cancer","year":"2011"},{"key":"10.1016\/j.canlet.2026.218355_bib77","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1002\/cam4.488","article-title":"Protecting the normal in order to better kill the cancer","volume":"4","author":"Liu","year":"2015","journal-title":"Cancer Med."},{"key":"10.1016\/j.canlet.2026.218355_bib78","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nrc3298","article-title":"Evolutionary dynamics of carcinogenesis and why targeted therapy does not work","volume":"12","author":"Gillies","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2026.218355_bib79","doi-asserted-by":"crossref","first-page":"6362","DOI":"10.1158\/0008-5472.CAN-12-2235","article-title":"Evolutionary approaches to prolong progression-free survival in breast cancer","volume":"72","author":"Silva","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218355_bib80","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nrc1369","article-title":"The anti-angiogenic basis of metronomic chemotherapy","volume":"4","author":"Kerbel","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2026.218355_bib81","series-title":"Evolution: a View from the 21st Century","author":"Shapiro","year":"2011"},{"key":"10.1016\/j.canlet.2026.218355_bib82","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3390\/biology6040042","article-title":"Living organisms author their read-write genomes in evolution","volume":"6","author":"Shapiro","year":"2017","journal-title":"Biology"},{"key":"10.1016\/j.canlet.2026.218355_bib83","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13039-020-0470-0","article-title":"Chromoanagenesis: a piece of the macroevolution scenario","volume":"13","author":"Pellestor","year":"2020","journal-title":"Mol. Cytogenet."},{"key":"10.1016\/j.canlet.2026.218355_bib84","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/ng.3687","article-title":"A saltationist theory of cancer evolution","volume":"48","author":"Markowetz","year":"2016","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2026.218355_bib85","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/j.1558-5646.2009.00942.x","article-title":"The animal within: carcinogenesis and the clonal evolution of cancer cells are speciation events sensu stricto","volume":"64","author":"Vincent","year":"2010","journal-title":"Evolution"},{"key":"10.1016\/j.canlet.2026.218355_bib86","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s10555-023-10123-0","article-title":"Is cancer an intelligent species?","volume":"42","author":"Nicolazzo","year":"2023","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.canlet.2026.218355_bib87","doi-asserted-by":"crossref","DOI":"10.1158\/1541-7786.MCR-19-1158","article-title":"Convergent evolution, evolving evolvability, and the origins of lethal cancer","volume":"18","author":"Pienta","year":"2020","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218355_bib88","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1002\/pros.23877","article-title":"Polyploid giant cancer cells: unrecognized actuators of tumorigenesis, metastasis, and resistance","volume":"79","author":"Amend","year":"2019","journal-title":"Prostate"},{"key":"10.1016\/j.canlet.2026.218355_bib89","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.pbi.2007.01.001","article-title":"Chromosome evolution","volume":"10","author":"Schubert","year":"2007","journal-title":"Curr. Opin. Plant Biol."},{"key":"10.1016\/j.canlet.2026.218355_bib90","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.tplants.2016.06.003","article-title":"Genome stability and evolution: attempting a holistic view","volume":"21","author":"Schubert","year":"2016","journal-title":"Trends Plant Sci."},{"key":"10.1016\/j.canlet.2026.218355_bib91","doi-asserted-by":"crossref","first-page":"554","DOI":"10.3390\/cancers16030554","article-title":"Macromutations yielding karyotype alterations (and the process(es) behind them) are the favored route of carcinogenesis and speciation","volume":"16","author":"Schubert","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canlet.2026.218355_bib92","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/gbe\/evv014","article-title":"Karyotype and gene order evolution from reconstructed extinct ancestors highlight contrasts in genome plasticity of modern rosid crops","volume":"7","author":"Murat","year":"2015","journal-title":"Genome Biol. Evol."},{"key":"10.1016\/j.canlet.2026.218355_bib93","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/ng.3813","article-title":"Reconstructing the genome of the most recent common ancestor of flowering plants","volume":"49","author":"Murat","year":"2017","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2026.218355_bib94","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nrg.2017.26","article-title":"The evolutionary significance of polyploidy","volume":"18","author":"Van de Peer","year":"2017","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.canlet.2026.218355_bib95","doi-asserted-by":"crossref","first-page":"E5379","DOI":"10.1073\/pnas.1702012114","article-title":"Reconstruction and evolutionary history of eutherian chromosomes","volume":"114","author":"Kim","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.canlet.2026.218355_bib96","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1017\/pab.2024.13","article-title":"Mass extinctions and their rebounds: a macroevolutionary framework","volume":"51","author":"Jablonski","year":"2025","journal-title":"Paleobiology"},{"key":"10.1016\/j.canlet.2026.218355_bib97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.semcancer.2021.10.006","article-title":"Polyploid giant cancer cells: an emerging new field of cancer biology","volume":"81","author":"Liu","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.canlet.2026.218355_bib98","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/jcp.21663","article-title":"Genome based cell population heterogeneity promotes tumorigenicity: the evolutionary mechanism of cancer","volume":"219","author":"Ye","year":"2009","journal-title":"J Cell Physiol"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526001187?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526001187?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T12:33:18Z","timestamp":1776083598000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383526001187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":99,"alternative-id":["S0304383526001187"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218355","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapy-induced rapid drug resistance driven by genome chaos and polyploid giant cancer cells","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218355","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"218355"}}